Neutral · 59/100Jul 30, 1:03 PM EDT
Xencor Shares Jump as Royalty Dispute with AstraZeneca's Alexion Is Resolved
XNCRAZN
Xencor (XNCR) announced a settlement with AstraZeneca's (AZN) Alexion subsidiary regarding royalty payments for Ultomiris, a rare disease treatment. The resolution removes a financial overhang that had pressured Xencor's stock since it cut its operating foreca…
- ▹Resolution of royalty dispute removes overhang, but no new regulatory or clinical catalysts.
- ▹Single-asset focus and reliance on partnership revenue cap upside.